Skip to main content
. 2022 May 16;25(e1):e18–e25. doi: 10.1136/ebmental-2022-300455

Table 2.

Analysis of main effects using the mixed-model L repeated measures analysis

Component N* Estimated least squares mean change scores of the PHQ-9† Estimated differences of change scores
(95% CI)
Effect size for Baseline-Week eight change scores‡
(95% CI)
Effect size for differences of change scores and their p values‡
(95% CI)
P value
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8
SM
 Presence 544 −0.79 −1.31 −1.50 −1.86 −1.70 −1.75 −1.79 −1.88 0.19 (−0.29 to 0.67) −0.65 (−0.78 to -0.53) 0.05 (−0.07 to 0.16) 0.44
 Absence 549 −1.08 −1.34 −1.41 −1.48 −1.51 −1.67 −1.86 −2.07 −0.78 (−0.92 to -0.65)
BA
 Presence 552 −0.85 −1.33 −1.42 −1.64 −1.60 −1.79 −1.85 −2.06 −0.17 (−0.65 to 0.31) −0.73 (−0.86 to -0.60) −0.04 (−0.16 to 0.08) 0.50
 Absence 541 −1.01 −1.31 −1.49 −1.70 −1.61 −1.63 −1.79 −1.90 −0.70 (−0.84 to -0.57)
CR
 Presence 544 −0.94 −1.05 −1.40 −1.60 −1.40 −1.47 −1.83 −2.02 −0.08 (−0.56 to 0.40) −0.75 (−0.89 to -0.62) −0.02 (−0.14 to 0.10) 0.74
 Absence 549 −0.93 −1.60 −1.52 −1.74 −1.82 −1.95 −1.82 −1.94 −0.68 (−0.81 to -0.56)
AT
 Presence 547 −0.75 −1.31 −1.30 −1.56 −1.71 −1.61 −1.73 −1.85 0.25 (−0.23 to 0.73) −0.67 (−0.80 to -0.54) 0.06 (−0.06 to 0.18) 0.31
 Absence 546 −1.12 −1.34 −1.62 −1.78 −1.50 −1.81 −1.91 −2.10 −0.76 (−0.89 to -0.63)
PS
 Presence 546 −0.80 −1.38 −1.48 −1.63 −1.63 −1.74 −1.86 −1.91 0.14 (−0.34 to 0.62) −0.71 (−0.84 to -0.57) 0.03 (−0.08 to 0.15) 0.56
 Absence 547 −1.07 −1.27 −1.44 −1.71 −1.58 −1.69 −1.79 −2.05 −0.72 (−0.86 to −0.60)

*In a factorial trial design, all 1093 participants included in the analysis were randomly assigned 1:1 to either presence or absence of each component.

†Minus value indicates depression reduction.

‡We calculated effect sizes (standardised mean differences) using the baseline SD for within-group change score and the week 8 SD for group differences.

AT, assertion training; BA, behavioural activation; CIDI, Composite International Diagnostic Interview; CR, cognitive restructuring; PHQ-9, Patient Health Questionnaire-9; PS, problem-solving; SM, self-monitoring